Table 3.
aCSF | Histamine | p | |
---|---|---|---|
P3–P6 | |||
fEPSP amplitude (mV) | 0.41 ± 0.10 | 0.34 ± 0.07 | 0.56 |
fEPSP duration (ms) | 241.58 ± 39.55 | 247.41 ± 35.16 | 0.92 |
fEPSP rise time (ms) | 30.02 ± 9.17 | 30.68 ± 8.59 | 0.94 |
fEPSP decay time (ms) | 211.55 ± 30.99 | 216.74 ± 27.77 | 0.92 |
Short-term plasticity (2 vs 1) | 1.48 ± 0.18 | 1.74 ± 0.30 | 0.48 |
Short-term plasticity (3 vs 1) | 1.55 ± 0.20 | 1.89 ± 0.37 | 0.44 |
Short-term plasticity (4 vs 1) | 1.47 ± 0.33 | 1.86 ± 0.48 | 0.52 |
Short-term plasticity (5 vs 1) | 1.48 ± 0.38 | 1.84 ± 0.52 | 0.58 |
Short-term plasticity (6 vs 1) | 1.52 ± 0.38 | 1.98 ± 0.59 | 0.53 |
P9–P12 | |||
fEPSP amplitude (mV) | 0.62 ± 0.15 | 0.50 ± 0.08 | 0.47 |
fEPSP duration (ms) | 224.74 ± 48.24 | 225.52 ± 55.01 | 0.99 |
fEPSP rise time (ms) | 24.22 ± 9.89 | 26.57 ± 10.94 | 0.88 |
fEPSP decay time (ms) | 200.52 ± 38.41 | 198.96 ± 44.26 | 0.98 |
Short-term plasticity (2 vs 1) | 1.01 ± 0.18 | 1.03 ± 0.12 | 0.93 |
Short-term plasticity (3 vs 1) | 0.97 ± 0.21 | 0.91 ± 0.15 | 0.82 |
Short-term plasticity (4 vs 1) | 0.93 ± 0.23 | 0.86 ± 0.20 | 0.83 |
Short-term plasticity (5 vs 1) | 0.95 ± 0.25 | 0.87 ± 0.19 | 0.82 |
Short-term plasticity (6 vs 1) | 0.96 ± 0.28 | 0.89 ± 0.21 | 0.83 |
P21–P35 | |||
fEPSP amplitude (mV) | 1.74 ± 0.75 | 1.50 ± 0.65 | 0.81 |
fEPSP duration (ms) | 196.93 ± 58.46 | 188.62 ± 51.16 | 0.92 |
fEPSP rise time (ms) | 18.56 ± 8.99 | 19.50 ± 9.22 | 0.94 |
fEPSP decay time (ms) | 178.37 ± 49.69 | 169.12 ± 42.80 | 0.89 |
Short-term plasticity (2 vs 1) | 0.92 ± 0.05 | 1.19 ± 0.21 | 0.26 |
Short-term plasticity (3 vs 1) | 0.79 ± 0.07 | 1.15 ± 0.25 | 0.20 |
Short-term plasticity (4 vs 1) | 0.71 ± 0.09 | 1.07 ± 0.21 | 0.17 |
Short-term plasticity (5 vs 1) | 0.70 ± 0.08 | 0.97 ± 0.17 | 0.20 |
Short-term plasticity (6 vs 1) | 0.67 ± 0.08 | 1.03 ± 0.20 | 0.14 |
aData are mean ± SEM; statistical comparisons by Mann–Whitney U test.